NasdaqGM - Nasdaq Real Time Price USD
Aura Biosciences, Inc. (AURA)
Tune into live earnings calls Now streaming directly on quote pages.
5.23
-0.57
(-9.83%)
At close: May 9 at 4:00:01 PM EDT
5.23
0.00
(0.00%)
After hours: May 9 at 4:05:10 PM EDT
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 562,145 | 6 |
| Sales | 63,147 | 9 |
| Net Shares Purchased (Sold) | 498,998 | 15 |
| Total Insider Shares Held | 1.02M | -- |
| % Net Shares Purchased (Sold) | 96.70% | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| KILROY CONOR Officer | Sale at price 5.49 per share. | Direct | 39,319 | Apr 16, 2025 |
| ELAZZOUZI AMY Officer | Sale at price 5.49 per share. | Direct | 4,925 | Apr 16, 2025 |
| BITETTI TERESA MARIE Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 31, 2025 |
| PLAVSIC MARK Chief Technology Officer | Sale at price 7.75 per share. | Direct | 16,670 | Feb 18, 2025 |
| DE LOS PINOS ELISABET Chief Executive Officer | Sale at price 7.75 per share. | Direct | 156,796 | Feb 18, 2025 |
| HOPKINS JANET JILL Officer | Sale at price 7.75 per share. | Direct | 19,638 | Feb 18, 2025 |
| ELAZZOUZI AMY Officer | Sale at price 7.75 per share. | Direct | 10,881 | Feb 18, 2025 |
| ELAZZOUZI AMY Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 3, 2025 |
| KILROY CONOR Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 3, 2025 |
| PLAVSIC MARK Chief Technology Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 3, 2025 |
| DE LOS PINOS ELISABET Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 3, 2025 |
| HOPKINS JANET JILL Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 3, 2025 |
| DE LOS PINOS ELISABET Chief Executive Officer | Sale at price 7.67 per share. | Direct | 122,381 | Jan 21, 2025 |
| ELAZZOUZI AMY Officer | Sale at price 7.67 per share. | Direct | 7,679 | Jan 21, 2025 |
| HOPKINS JANET JILL Officer | Sale at price 9.36 per share. | Direct | 110,663 | Nov 18, 2024 |
| DE LOS PINOS ELISABET Chief Executive Officer | Sale at price 10.74 per share. | Direct | 98,788 | Oct 29, 2024 |
| ELAZZOUZI AMY Officer | Sale at price 10.74 per share. | Direct | 5,938 | Oct 29, 2024 |
| FEDER JULIE B Chief Financial Officer | Conversion of Exercise of derivative security at price 2.74 - 5.48 per share. | Direct | 86,532 | Oct 18, 2024 |
| DE LOS PINOS ELISABET Chief Executive Officer | Conversion of Exercise of derivative security at price 2.74 per share. | Direct | 68,478 | Oct 18, 2024 |
| FEDER JULIE B Chief Financial Officer | Sale at price 12.03 per share. | Direct | 302,361 | Oct 18, 2024 |
| DE LOS PINOS ELISABET Chief Executive Officer | Sale at price 12.04 per share. | Direct | 300,839 | Oct 18, 2024 |
| PLAVSIC MARK Chief Technology Officer | Sale at price 9.85 per share. | Direct | 72,723 | Oct 16, 2024 |
| DE LOS PINOS ELISABET Chief Executive Officer | Conversion of Exercise of derivative security at price 5.76 per share. | Direct | 31,530 | Sep 27, 2024 |
| SRIVASTAVA SAPNA Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 20, 2024 |
| MATTESSICH ANTONY CHARLES Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 20, 2024 |
| JOHNSON DAVID MICHAEL Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 20, 2024 |
| KILROY CONOR General Counsel | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Apr 2, 2024 |
| FEDER JULIE B Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 1, 2024 |
| DE LOS PINOS ELISABET Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 1, 2024 |
| HOPKINS JANET JILL Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 1, 2024 |
| FEDER JULIE B Chief Financial Officer | Sale at price 7.64 per share. | Direct | 50,521 | Jan 23, 2024 |
| DE LOS PINOS ELISABET Chief Executive Officer | Sale at price 7.64 per share. | Direct | 121,141 | Jan 23, 2024 |
| MATRIX CAPITAL MANAGEMENT COMPANY, LP Beneficial Owner of more than 10% of a Class of Security | Purchase at price 7.02 per share. | Indirect | 10,951,200 | Nov 9, 2023 |
| JOHNSON DAVID MICHAEL Director | Purchase at price 7.17 - 7.30 per share. | Indirect | 1,434,987 | Nov 8, 2023 |
| FEDER JULIE B Chief Financial Officer | Conversion of Exercise of derivative security at price 2.74 per share. | Direct | 10,686 | Nov 6, 2023 |
| DE LOS PINOS ELISABET Chief Executive Officer | Conversion of Exercise of derivative security at price 2.74 per share. | Direct | 10,412 | Nov 6, 2023 |
| FEDER JULIE B Chief Financial Officer | Sale at price 12.07 per share. | Direct | 47,054 | Nov 6, 2023 |
| DE LOS PINOS ELISABET Chief Executive Officer | Sale at price 12.03 per share. | Direct | 89,611 | Nov 6, 2023 |
| HOPKINS JANET JILL Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Nov 1, 2023 |
| FEDER JULIE B Chief Financial Officer | Sale at price 6.82 per share. | Direct | 23,091 | Oct 30, 2023 |
| DE LOS PINOS ELISABET Chief Executive Officer | Sale at price 6.83 per share. | Direct | 65,478 | Oct 30, 2023 |
| JOHNSON DAVID MICHAEL Director | Purchase at price 8.27 - 8.61 per share. | Direct | 168,175 | Oct 4, 2023 |
Related Tickers
CLSD Clearside Biomedical, Inc.
0.8588
+1.14%
ZNTL Zentalis Pharmaceuticals, Inc.
1.2300
-2.38%
JBIO Jade Biosciences, Inc.
8.65
-3.89%
TYRA Tyra Biosciences, Inc.
10.09
+0.20%
ZYME Zymeworks Inc.
11.31
-0.13%
ADVM Adverum Biotechnologies, Inc.
2.8100
-9.94%
LVTX LAVA Therapeutics N.V.
1.2500
-1.57%
CGEM Cullinan Therapeutics, Inc.
7.54
-2.96%
VRDN Viridian Therapeutics, Inc.
12.39
-3.05%
YMAB Y-mAbs Therapeutics, Inc.
3.8900
-3.71%